The Evaluation of Left Ventricular Hypertrophy in Hypertensive Patients with Subclinical Hyperthyroidism
Authors:
- 1 January 2005
- journal article
- Published by Japan Endocrine Society in Endocrine Journal
- Vol. 52 (4) , 421-425
Abstract
The aim of this prospective cross-sectional study was to investigate the hypertrophic effects of endogenous subclinical hyperthyroidism on myocardium and early development of left ventricular hypertrophy (LVH) in essential hypertensive patients accompanied by endogenous subclinical hyperthyroidism. A total of 31 consecutive patients with stage I hypertension were included in the study. Sixteen of them also had endogenous subclinical hyperthyroidism that they were unaware before. The patients and the controls formed out of ten healthy subjects all underwent an investigation of thyroid functions and cardiologic evaluation. The mean wall thickness of the left ventricle in the stage I hypertensive group with endogenous subclinical hyperthyroidism (group I) was significantly increased as compared with both hypertensive patients without thyroid disease (group II) and the control subjects. The mean left ventricle mass was also significantly higher in group I than group II. Both of the patients' groups had an increased prevalence of LVH as compared with the controls. In this study, hypertensive patients with subclinical hyperthyroidism presented more increase in left ventricular mass, suggesting that subclinical hyperthyroidism may contribute to left ventricular hypertrophy forming a natural progression to hypertension. The hypertensive population should always be screened for endogenous subclinical hyperthyroidism, and should be examined for the criteria of left ventricular hypertrophy by echocardiography in early stages.Keywords
This publication has 17 references indexed in Scilit:
- Mechanisms and management of hypertensive heart disease: from left ventricular hypertrophy to heart failureMedical Clinics of North America, 2004
- The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood PressureThe JNC 7 ReportJAMA, 2003
- Atrial Fibrillation in HypertensionHypertension, 2003
- Cardiovascular haemodynamics and cardiac autonomic control in patients with subclinical and overt hyperthyroidismEuropean Journal of Endocrinology, 2001
- Cardiac Function, Physical Exercise Capacity, and Quality of Life during Long-Term Thyrotropin-Suppressive Therapy with Levothyroxine: Effect of Individual Dose TailoringThe Journal of Clinical Endocrinology & Metabolism, 2000
- Cardiac hypertrophy as a result of long-term thyroxine therapy and thyrotoxicosis.Heart, 1996
- Cellular and signaling mechanisms of cardiac hypertrophyJournal of Cardiovascular Nursing, 1994
- The thyroid and the heart.Circulation, 1993
- Prognostic Implications of Echocardiographically Determined Left Ventricular Mass in the Framingham Heart StudyNew England Journal of Medicine, 1990
- Effect of thyroid replacement therapy on the frequency of benign atrial and ventricular arrhythmiasJACC, 1989